The Mexico City government has issued amendments to the local Health Law to expand women’s rights to medical care, especially those going through menopause, to detect ovarian cancer.
In a decree starting Tuesday and disclosed in the Official Gazette, it was reported that women should receive a preventive and timely diagnosis through the use of transvaginal ultrasounds and the CA 125 tumor marker for the detection of carcinomas of this type.
It emphasizes that such tests should be applied, above all, to women who have gone through or are going through menopause, prioritizing those who are at high risk with a history of breast and ovarian cancer in their immediate family.
Likewise, the Mexico City government plans to develop programs for the training of medical personnel to identify symptoms and early diagnosis of ovarian cancer.
In addition, it will be in charge of the ongoing promotion of information campaigns on the prevention and detection of the disease, which is intended for the entire population of Mexico City.